JP2023503722A5 - - Google Patents
Info
- Publication number
- JP2023503722A5 JP2023503722A5 JP2022556456A JP2022556456A JP2023503722A5 JP 2023503722 A5 JP2023503722 A5 JP 2023503722A5 JP 2022556456 A JP2022556456 A JP 2022556456A JP 2022556456 A JP2022556456 A JP 2022556456A JP 2023503722 A5 JP2023503722 A5 JP 2023503722A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- independently
- substituted
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025279753A JP2026076156A (ja) | 2019-11-26 | 2025-12-24 | 核酸および半減期モチーフを含む化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962940835P | 2019-11-26 | 2019-11-26 | |
| US62/940,835 | 2019-11-26 | ||
| PCT/US2020/062358 WO2021108662A1 (en) | 2019-11-26 | 2020-11-25 | Compound comprising a nucleic acid and a half-life extension motif |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025279753A Division JP2026076156A (ja) | 2019-11-26 | 2025-12-24 | 核酸および半減期モチーフを含む化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023503722A JP2023503722A (ja) | 2023-01-31 |
| JP2023503722A5 true JP2023503722A5 (cg-RX-API-DMAC10.html) | 2023-12-04 |
| JP7821737B2 JP7821737B2 (ja) | 2026-02-27 |
Family
ID=74046141
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556456A Active JP7821737B2 (ja) | 2019-11-26 | 2020-11-25 | 核酸および半減期モチーフを含む化合物 |
| JP2025279753A Pending JP2026076156A (ja) | 2019-11-26 | 2025-12-24 | 核酸および半減期モチーフを含む化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025279753A Pending JP2026076156A (ja) | 2019-11-26 | 2025-12-24 | 核酸および半減期モチーフを含む化合物 |
Country Status (11)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4398939A1 (en) * | 2021-09-10 | 2024-07-17 | Guardian Therapeutics, LLC | Fatty acid conjugates of nucleic acids |
| EP4522742A2 (en) | 2022-05-13 | 2025-03-19 | Alnylam Pharmaceuticals, Inc. | Single-stranded loop oligonucleotides |
| WO2024238385A2 (en) | 2023-05-12 | 2024-11-21 | Alnylam Pharmaceuticals, Inc. | Single-stranded loop oligonucleotides |
| WO2026163078A1 (en) | 2025-01-29 | 2026-08-06 | Novartis Ag | Compounds targeting dmpk for the treatment of myotonic dystrophy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2586704B1 (fr) * | 1985-09-04 | 1987-12-18 | Centre Nat Rech Scient | Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation et a un groupe chimique activable, leur synthese et leurs applications a titre de nucleases artificielles specifiques de sequences. centre national de la recherche scientifique (cnrs) |
| US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
| WO2015006740A2 (en) * | 2013-07-11 | 2015-01-15 | Alnylam Pharmaceuticals, Inc. | Oligonucleotide-ligand conjugates and process for their preparation |
| US10588980B2 (en) * | 2014-06-23 | 2020-03-17 | Novartis Ag | Fatty acids and their use in conjugation to biomolecules |
| EP3603648B1 (en) * | 2017-03-29 | 2025-09-17 | Shionogi & Co., Ltd | Complex of nucleic acid medicine and multibranched lipid |
| JP7583712B2 (ja) * | 2018-05-30 | 2024-11-14 | ノバルティス アーゲー | 脂質修飾された核酸化合物および方法 |
-
2020
- 2020-11-25 CN CN202080094151.1A patent/CN115397471B/zh active Active
- 2020-11-25 JP JP2022556456A patent/JP7821737B2/ja active Active
- 2020-11-25 US US17/778,372 patent/US20230158150A1/en active Pending
- 2020-11-25 KR KR1020227021677A patent/KR20220150881A/ko active Pending
- 2020-11-25 CA CA3161669A patent/CA3161669A1/en active Pending
- 2020-11-25 WO PCT/US2020/062358 patent/WO2021108662A1/en not_active Ceased
- 2020-11-25 KR KR1020267020310A patent/KR20260111659A/ko active Pending
- 2020-11-25 MX MX2022006097A patent/MX2022006097A/es unknown
- 2020-11-25 CN CN202610027229.7A patent/CN121971633A/zh active Pending
- 2020-11-25 EP EP20829416.5A patent/EP4065172A1/en active Pending
- 2020-11-25 AU AU2020391218A patent/AU2020391218B2/en active Active
- 2020-11-25 BR BR112022009976A patent/BR112022009976A2/pt unknown
-
2022
- 2022-05-25 IL IL293341A patent/IL293341B2/en unknown
-
2025
- 2025-12-24 JP JP2025279753A patent/JP2026076156A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023503644A5 (cg-RX-API-DMAC10.html) | ||
| JP7297676B2 (ja) | 新規なカルボニル脂質、および核酸を送達するための脂質ナノ粒子製剤 | |
| EP3718572B1 (en) | Nucleic acid, composition and conjugate containing nucleic acid, preparation method and use | |
| JP6853193B2 (ja) | 核酸複合体 | |
| US12577565B2 (en) | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | |
| CN113636947B (zh) | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 | |
| CN114929282B (zh) | 脱唾液酸糖蛋白受体介导的治疗活性缀合物的递送 | |
| WO2020233655A1 (zh) | 核酸、药物组合物与缀合物及制备方法和用途 | |
| WO2020233650A1 (zh) | 核酸、药物组合物与缀合物及制备方法和用途 | |
| TW202043474A (zh) | 一種新化合物及其應用 | |
| AU2020282453A1 (en) | Nucleic acid, pharmaceutical composition and conjugate, preparation method and use | |
| WO2021037205A1 (zh) | 化合物和药物缀合物及其制备方法和用途 | |
| AU2002314227B2 (en) | Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules | |
| EP4541893A1 (en) | Sirna molecule for regulating pcsk9 gene activity | |
| TW202604464A (zh) | 用於脂質奈米顆粒之galnac脂質化合物 | |
| TW593328B (en) | Proactive antitumor compounds | |
| US7338805B2 (en) | Labeling reagents, methods for synthesizing such reagents and methods for detecting biological molecules | |
| JP2024544975A5 (cg-RX-API-DMAC10.html) | ||
| WO2012089945A1 (fr) | Dendrimères à terminaison saccharide à visée anti-inflammatoire | |
| US20110130557A1 (en) | Intercalating triplexes and duplexes using aryl naphthoimidazol and process for the preparation thereof | |
| JP2024543372A5 (cg-RX-API-DMAC10.html) | ||
| JP2001131074A (ja) | シアル酸誘導体を有効成分として含む医薬 | |
| EP2081944B1 (fr) | Nouveaux derives morphiniques | |
| JPH0782291A (ja) | 水溶性アンスラサイクリン誘導体 | |
| RU2816898C2 (ru) | Нуклеиновая кислота, фармацевтическая композиция и конъюгат, способ получения и применение |